Gelonghui, April 29 | Longjin Pharmaceutical (002750.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 26.3884 million yuan, up 22.43% year on year; net profit attributable to shareholders of listed companies was 4.4918 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 6.1091 million yuan; basic earnings per share - 0.0112 yuan.
龙津药业(002750.SZ)：一季度净亏损449.18万元
Longjin Pharmaceutical (002750.SZ): Net loss of 4.4918 million yuan in the first quarter
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated